Anonymous
Guest
Anonymous
Guest
In spite of what you hear, this place is horrible. Takeda is eliminating most of the bonuses and it is very political and many in senior management are clueless. This company has never produced a drug that is marketed having in-licensed Velcade, Mepact, and Adcetris from others. TAK-700 just failed and 9708 is too late and if approved in 2 years will be hard to overcome the data from Celgene and Onyx.